Aspen Pharmacare Articles
South Africa's drugmakers bemoan low medicine price hikes
27 January 2013
Aspen and Adcock win South Africa preference tender
14 August 2012
Pierre Fabre gains approval for fibromyalgia drug Joncia in Australia; TGA cancels approval for four painkillers
22 November 2011
J&J unit Tibotec signs multiple deals with generic drugmakers for access to new HIV treatment rilpivirine pre-approval
31 January 2011
Aspen completes buyout of Sigma pharma business for $900 million
17 January 2011
Sigma finally accepts takeover bid from Aspen, but only for its pharma division, with a price tag of A$900 million
16 August 2010
Aspen confirms bid for Australia’s Sigma but, as expected, at a reduced A$0.55 per share
7 July 2010
Sigma Pharma slumps to a six-week low, as proposed buyer Aspen looks set to lower offer price for the firm
6 July 2010
Showing 1-13 of 13 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
